GT-20029 is discussed as a potential hairloss treatment, with concerns about its safety and systemic absorption compared to finasteride. Users express skepticism about its effectiveness and safety, noting that it may not surpass existing treatments like finasteride and minoxidil.
A user discusses their experience with hairloss, noting they don't notice shedding despite using finasteride, minoxidil, and tretinoin. Others share similar experiences, suggesting that shedding varies and may not occur for everyone using these treatments.
Stopping minoxidil causes significant hairloss, as continued use is necessary for maintaining gains. Combining minoxidil with finasteride may help maintain hair, but both treatments are typically lifelong commitments.
The user shared a 15-month hairloss treatment update using Dutasteride (0.5mg/day), Minoxidil (5% foam twice daily), Nizoral (1% every 3 days), and a 1.5mm derma roller (twice a month), along with a multivitamin, exercise, low sugar diet, hydration, and consistent sleep. They started seeing results after 6-9 months, with significant improvement at the 1-year mark, and apply Minoxidil the day after derma rolling.
A user shared their experience with hairloss treatments, including finasteride, minoxidil, and RU58841, which improved their hair from a diffuse NW3 to a solid NW2 - 2.5. They noticed significant changes in how people treated them after regrowing their hair, suggesting that attractiveness can greatly impact social interactions and opportunities.
User shared hairloss progress using 0.5 oral fin daily, 1ml liquid minox daily, Vitamin D, Biotin, and micro-needling. Regrowth improved from year 2 to year 3, showing medication needs time for full benefit.
User discusses Pyrilutamide's effectiveness for hairloss, needing more time for results. Others suggest waiting 6-12 months and ask about side effects.
A user shared their 10-year hairloss journey, detailing treatments including minoxidil (Kirkland and Alopexy 5%), finasteride, and recently starting dutasteride. They experienced varying results, with significant improvement from minoxidil and finasteride, and are currently seeing positive effects from dutasteride without side effects.
AnagenInc is ready to produce a hairloss treatment called GT20029 if there is enough demand. People are discussing combining it with other treatments like finasteride and minoxidil, and some are concerned about the legitimacy and safety of gray market products.
This user experienced severe hairloss, but was able to successfully treat it with finasteride over a two year period. Despite experiencing multiple shedding cycles while on the medication, Mission5896 reported that their hair continued to get thicker and stronger. Additionally, they tried both minoxidil orally and topically, but only found success with finasteride.
A user's progress with treating hairloss using 1mg finasteride per day, with reports of no noticeable side effects and positive results. Other users have shared their experiences with different treatments, such as Dutasteride and Minoxidil.
A user who experienced hairloss after switching from finasteride to dutasteride and is seeking advice whether it is an indication the treatment isn't working. Replies suggest that shedding is common at first due to dutasteride's longer half-life, but patience may be necessary before results are seen.
A person experiencing hairloss is using finasteride and considering minoxidil but is worried about side effects like heart palpitations. They seek advice on continuing minoxidil, trying alternatives like microneedling, or considering a hair transplant.
A 19-year-old experiencing mild hairloss plans to start finasteride and use Nizoral, avoiding minoxidil for now. Others share their experiences with finasteride, noting minimal side effects and advising against worrying about potential negative effects.
The user is experiencing aggressive hairloss and has been using minoxidil with initial success but is now seeing thinning again. They are considering starting finasteride and dermarolling while waiting for a dermatologist appointment.
A user shared their hairloss journey, using finasteride since age 18 and adding dutasteride at 30, which halted hairloss and promoted regrowth. They take finasteride daily and dutasteride three times a week, experiencing reduced libido and drier skin as side effects.
The conversation discusses skepticism and diminishing excitement around the hairloss treatment PP405 due to unclear trial results. It also mentions other treatments like finasteride, minoxidil, VDPHL01 (extended-release minoxidil), and GT20026 as potential options for hairloss management.
Finasteride is used for hairloss, with mixed reports of no side effects and claims of long-term negative effects known as Post Finasteride Syndrome (PFS). The conversation debates the existence and causes of PFS, with differing opinions on whether it is psychological or real.
The conversation is about sourcing RU58841 for hairloss treatment in Australia and discusses the lack of effective alternatives. Alternatives mentioned include Kx826, fluridil, cb, alfatradiol, and topical spiro, but they are considered weak compared to RU58841.
Follicium XR™ is a topical treatment for hairloss containing RU58841, AHK-Cu, GHK-Cu Peptide, caffeine, D-Biotin, methylene blue, keratin, and spermidine. RU58841 is considered the most effective ingredient, but concerns exist about its stability in water.
The user experienced hairloss issues after switching from finasteride to dutasteride and back, with stress and seborrheic dermatitis affecting hair quality. They plan to continue finasteride, treat seborrheic dermatitis, and monitor nutrient levels, considering low-dose oral minoxidil if safe.
The conversation is optimistic about future hairloss treatments, highlighting Veradermics, Breezula, and PP405 as promising options expected by 2027-2028. The user expresses hope that these developments will prevent future generations from experiencing the same struggles with hairloss.
A trans man experiencing hairloss after starting testosterone treatment has seen positive results using topical minoxidil and finasteride, though his hair remains thin. He is considering continuing his current treatment and exploring additional options like microneedling and Breezula, while acknowledging the impact of testosterone on hairloss.
A 20-year-old male experiencing hairloss is considering switching from topical finasteride to oral finasteride after using minoxidil and topical finasteride. He is unsure whether to switch now or wait until his hair recovers, as he is experiencing significant shedding.
The user experienced significant hairloss after 9 months of using 0.5mg dutasteride and oral minoxidil, possibly due to alopecia areata. It is advised to consult a doctor for accurate diagnosis and treatment, as dutasteride and finasteride may not be effective.
PP405 is considered a promising hairloss treatment, potentially replacing minoxidil but not finasteride. Users are hopeful for future treatments like GT20029 and VDPHL01, while remaining cautious about effectiveness and side effects.
A user experienced significant hairloss after starting microneedling, despite using dutasteride and topical minoxidil. They are advised to consult a doctor as the shedding pattern is unusual and may indicate alopecia areata or other scalp conditions.
A peptide-based hairloss treatment, PP405, reportedly increased hair density by 62% in 90 days, but these claims are unverified and met with skepticism. Users compared PP405 to Minoxidil and Finasteride, expressing doubts about its effectiveness without more evidence.